ArticleDiscover oncology2026
Construction of immune related genes predictive models of elderly rectal cancer patients based on machine learning.
Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A GIMAP family signature for prognostic prediction and immune characterization in hepatocellular carcinoma patients.Discover oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThere were not many studies on predictive indicators of elderly rectal cancer (ERC) based on transcriptome level. Immune related genes (IRGs) have been shown to be associated with cancer, however, their role in ERC had not been fully explored.
methodsFor the first time, IRGs associated with ERC prognosis were identified using univariate Cox regression analysis. Based on the screened IRGs, consistent clustering analysis and prognostic difference analysis were conducted and a prognostic model was constructed through multivariate Cox regression. The model was validated on an independent dataset. The patients were grouped based on the median risk score. Simultaneously conduct immune infiltration analysis, enrichment analysis and drug sensitivity evaluation.
resultsThe prognostic value of IRGs in ERC patients had been comprehensively analyzed for the first time and identified 3 IRGs with prognostic values. Consensus cluster analysis based on 3 IRGs revealed that the two identified clusters had prognostic differences. A prognostic model was constructed based on 3 IRGs and validated in an independent dataset. The signature was an independent risk factor for ERC patients, 3 IRGs were related to the immune microenvironment of ERC.
conclusionsThis research provides a fundamental theoretical basis for guiding the treatment of ERC patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.